Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biomea Fusion Inc (NQ: BMEA )

32.35 +1.64 (+5.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,145,450
Open 32.37
Bid (Size) 32.55 (3)
Ask (Size) 32.88 (1)
Prev. Close 30.71
Today's Range 29.51 - 36.68
52wk Range 2.840 - 31.54
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is Cathie Wood Giving Up on Xpeng (XPEV) Stock?
Investors in Xpeng (XPEV) are wondering if Cathie Wood is giving up on the stock after a recent selloff during a strong rally. 
Via InvestorPlace
What's Going On With Biomea Fusion Stock?
Biomea Fusion Inc (NASDAQ: BMEA) shares are trading higher. The company reported fourth-quarter results after the bell and announced an offering Wednesday morning. Several analysts are out with... 
Via Benzinga

Performance

YTD
+281.49%
+281.49%
1 Month
+156.95%
+156.95%
3 Month
+341.94%
+341.94%
6 Month
+219.66%
+219.66%
1 Year
+625.34%
+625.34%

More News

Read More
Dear SBNY Stock Fans, Mark Your Calendars for April 5
Via InvestorPlace
BMEA Stock: Biomea Fusion Pops on Public Offering News
Via InvestorPlace
Biomea Fusion Announces Proposed Public Offering of Common Stock
From Biomea Fusion, Inc.
Via Globe NewsWire
Where Biomea Fusion Stands With Analysts
Via Benzinga
Why Shares of Biomea Fusion Jumped This Week
Via The Motley Fool
Analyst Expectations for Biomea Fusion's Future
Via Benzinga
Biomea Fusion Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
From Biomea Fusion, Inc.
Via Globe NewsWire
Nasdaq Dips 90 Points; Walgreens Posts Upbeat Q2 Results
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Stocks Mixed After Upbeat Consumer Confidence Data
Via Talk Markets
Dow Rises 50 Points; Harmony Biosciences Shares Plunge
Via Benzinga
Biomea Fusion (NASDAQ: BMEA) Reports Positive Initial Findings From the COVALENT-111 Phase II Study of BMF-219 for the Treatment of Type 2 Diabetes
Via Spotlight Growth
What's Driving Biomea Fusion Shares Higher Today?
Via Benzinga
Nasdaq Down Over 50 Points; US Goods Trade Deficit Widens Slightly
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Biomea Fusion Announces Positive Data from Initial Cohorts of Ongoing Phase II Study (COVALENT-111) of BMF-219 in Patients with Type 2 Diabetes; 100 mg Cohort 3 Demonstrated an 89% Response Rate and 1% Median Reduction in HbA1c at Day 28
From Biomea Fusion, Inc.
Via Globe NewsWire
Biomea Fusion to Host Conference Call and Webcast to Discuss Initial Phase II Clinical Data for BMF-219 in Subjects with Type 2 Diabetes on March 28th, 2023 at 8:30 a.m. ET
From Biomea Fusion, Inc.
Via Globe NewsWire
Rise in Biotech Innovations Generating Hope as Pancreatic Cancer Survival Rates Climb
Via FinancialNewsMedia
Exposures Product Safety
Biomea Fusion To Participate In Upcoming Investor Events
From Biomea Fusion, Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
Via Benzinga
Biomea Fusion Doses First Patient in Phase I/Ib Clinical Trial (COVALENT-102) of BMF-219 in KRAS Mutant Solid Tumors
From Biomea Fusion, Inc.
Via Globe NewsWire
US Stocks Edge Lower; Bank of America Profit Tops Views
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.